Quan Zhou

Zhejiang International Studies University CN

0000-0002-0184-4884

Publications

2,768

Citations

H-Index

i10-Index

20.86

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy OA

Chen Huang, Wentao Huang, Lifen Zhang, Chunyu Zhang, Chengqian Zhou - Pharmaceutics, 2022

Cited by 28 Semantic Scholar

VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T1-Weighted Magnetic Resonance Imaging OA

Chunyu Zhang, Wentao Huang, Chen Huang, Chengqian Zhou, Yukuan Tang - Frontiers in Bioengineering and Biotechnology, 2022

Cited by 11 Semantic Scholar

Low-concentration sevoflurane inhalation in treating MK801-induced schizophrenia like disease in mice and a feasibility study of schizophrenia patients OA

Tianyun Zhao, Shi Ziwen, Nongxi Ling, Ying Xu, Jingwen Qin - Unknown Venue, 2020

Cited by 0 Semantic Scholar

[Type III familial hemophagocytic lymphohistiocytosis susceptibility gene UNC13D involves in homologous recombination repair].

Lixian Chang, Hui-min Zeng, Quancai Zhou, Min Gao, Wei Wei - Zhongguo shi yan xue ye xue za zhi, 2013

Cited by 0 Semantic Scholar

Research Topics

Immune cells in cancer (6) interferon and immune responses (6) Epigenetics and DNA Methylation (5) Cancer, Hypoxia, and Metabolism (5) Reproductive System and Pregnancy (5)

Affiliations

Zhejiang International Studies University

CN 2026 - 2026

Nanchang University

CN 2017 - 2017

Shandong University

CN 2016 - 2016

University of California, Los Angeles

US 2025 - 2015

China Pharmaceutical University

CN 2023 - 2022

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Quan Zhou

Publication & Citation Trends

Publications

Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy OA

VHPKQHR Peptide Modified Ultrasmall Paramagnetic Iron Oxide Nanoparticles Targeting Rheumatoid Arthritis for T1-Weighted Magnetic Resonance Imaging OA

Low-concentration sevoflurane inhalation in treating MK801-induced schizophrenia like disease in mice and a feasibility study of schizophrenia patients OA

[Type III familial hemophagocytic lymphohistiocytosis susceptibility gene UNC13D involves in homologous recombination repair].

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back